The common cold at the turn of the millennium

American Journal of Rhinology

Volumn 14, Issue 5, 2000, Pages 339-343

  Van Cauwenberge, Paul B ^a   Van Kempen, Muriel J P ^a   Bachert, Claus ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE; CYTOKINE; INTERLEUKIN 8;

CLINICAL FEATURE; COMMON COLD; CONFERENCE PAPER; CYTOKINE RELEASE; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOVIRUS; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

EID: 0033764407     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065800781329555     Document Type: Conference Paper

References (49)

1. Turner RB. Epidemiology, pathogenesis and treatment of the common cold. Ann Allergy Asthma Immunol 78:531-539, 1997.
2. Roseler S, Holtappels G, Wagenmann M, et al. Elevated levels of interleukins IL-1beta, IL-6, IL-8 i, IL-8 in naturally acquired viral rhinitis. Eur Arch Oto-Rhinolaryngol 252(Suppl):S61-S66, 1995.
3. Kirkpatrick GL. The Common Cold. Primary Care 23:657-675, 1996.
4. Gwaltney JM Jr, and Hendley JO. Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol 116.828-833, 1982.
5. Hendley JO, and Gwaltney JM Jr Mechanisms of transmission of rhinovirus infections. Epidemiol Rev 10:243-258, 1988.
6. Staunton DE, Merluzzi VS, Rothlein R, et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56:849-853, 1989.
7. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-1. Cell 56:839-847, 1989.
8. Winther B, Gwaltney JM Jr, Mygind N, et al. Sites of rhinovirus recovery after point-inoculation of the upper airway. JAMA 256:1763-1767, 1986.
9. Gwaltney JM Jr, Phillips CD, Miller RD, et al. Computed tomographic study of the common cold. N Engl J Med 330:25-30, 1994.
10. Gem JE, Busse and WW. The effects of rhinovirus infections on allergic airway responses. Am J Respir Crit Care 152:S40-S45, 1995.
11. Jackson GG, and Muldoon RL. Viruses causing common respiratory infections in man. J Infect Dis 127:328-355, 1973.
12. Monto AS. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev 16:351-373, 1994.
13. Mäkelä MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 36:539-542, 1998.
14. Hyypiä T, Puhakka T, Ruuskanen O, et al. Molecular diagnosis of human rhinovirus infections: comparison with virus isolation. J Clin Microbiol 36:2081-2083, 1998.
15. Arruda A, Pitkaranta A, Witek TJ Jr, et al. Frequency and natural history of rhinovirus infections in adults during autumn J Clin Microbiol 35:2864-2868, 1997.
16. Winther B, Gwaltney JM Jr, and Hendley JO Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis 141:839-845, 1990.
17. Arruda E, Boyle TR, Winther B, et al. Localisation of human rhinovirus replication in the upper respiratory tract by in situ hybridisation. J Infect Dis 171:1329-1333, 1995.
18. Bardin PG, Johnston SL, Sanderson G, et al. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. Am J Respir Cell Mol Biol 10:207-213, 1994.
19. Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 157: 133-142, 1988.
20. Levandowski RA, Weaver CW, and Jackson GG. Nasal-secretion leucocyte populations determined by flow cytometry during acute rhinovirus infection. J Med Virol 25:423-432, 1988.
21. Winther B, Farr B, Turner RB, et al. Histopathologic examination of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol (Stock) 413(Suppl):19-24, 1984.
22. Douglas RG Jr, Alford RH, Cate TR, et al. The leucocyte response during viral respiratory illness in man. Ann Intern Med 64:521-530, 1966.
23. Turner RB. Rhinovirus infection of human embryonic lung fibroblast induces the production of a chemoattractant for polymorphonuclear leucocytes. J Infect Dis 157:346-350, 1988.
24. Subauste MC, Jacoby DB, Richards SM, et al. Infection of a human respiratory epithelial cell line with rhinovirus. J Clin Invest 96:549-557, 1995.
25. Noah TL, and Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 265:L472-L478, 1993.
26. Matsukura S, Kokubu F, Noda H, et al. Expression of IL-6, IL-8 a, IL-8 and RANTES on human bronchial epithelial cells, NCI-H292. induced by influenza virus A. J Allergy Clin Immunol 98 1080-1087, 1996.
27. Noah TL, Henderson FW, Wortman IA, et al. Nasal cytokine production in viral acute respiratory infection of childhood. J Infect Dis 171:584-592, 1995.
28. Proud D, Gwaltney JM Jr, Hendley JO, et al. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 169:1007-1013, 1994
29. Zhu Z, Tang W, Ray A, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. J Clin Invest 97:421-430, 1996.
30. Bachert C, van Kempen M, Höpken K, et al. Elevated levels of mediators, cytokines and sICAM-1 i, cytokines and sICAM-1 in naturally acquired viral rhinitis. Submitted.
31. Turner RB, Weingand KW, Yeh C-H, et al. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis 26:840-846, 1998.
32. Teran LM, Johnston SL, Schröder J-M, et al. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Resp Crit Care Med 115:1362-1366, 1997
33. Kaiser L, Lew D, Hirschel B, et al. Effects of antibiotic treatment in the subset of common cold patients who have bacteria in nasopharyngeal secretions. Lancet 347:1507-1510, 1996.
34. Mainous AG III, Hueston WJ, and Clark JR. Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold? J Fam Pract 42:357-361, 1996.
35. Hendley JO. The host response, not the virus, causes the symptoms of the common cold. Clin Infect Dis 26:847-848, 1998.
36. Sperber SJ, and Hayden FG. Chemotherapy of rhinovirus colds. Antimicrob Agents Chemother 32:409-419, 1988.
37. Hayden FG, Mills SE, and Johns ME. Human tolerance and histopathologic effects of longterm administration of intranasal interferon-alpha2. J Infect Dis 148:914-921, 1983.
38. Van Cauwenberge P, Ectors L, and Janssens M. Prophylactic antipicornaviral treatment of experimentally induced rhinovirus infection in human volunteers. Abstracts of the Collegium Otorhinolaryngologicum Amicitiae Sacrum Estoril Portugal 17-18: 1994.
39. Schiff GM, and Sherwood JR. Clinical activity of Pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J Infect Dis 181:20-26, 2000.
40. Marlin SD, Stauton DE, Springer TA, et al. A soluble form of ICAM-1 inhibits rhinovirus infection. Nature 344:70-72, 1990.
41. Turner RB, Wecker MT, Pohl G, et al. Efficacy of Tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection. JAMA 281:1797-1804, 1999.
42. Sperber SJ, Hendley O, Hayden FG, et al. Effects of naproxen on experimental rhinovirus colds: a randomized, double blind, controlled trial. Ann Intern Med 117:37-41, 1992.
43. Graham NM, Burrell CJ, Douglas RM, et al. Adverse effects of aspirin, acetaminophen and ibuprofen on immune function, viral shedding and clinical status in rhinovirus infected volunteers. J Infect Dis 162:1277-1282, 1990.
44. Gustafson LM, Proud D, Hendley JO, et al. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 97:1009-1014, 1996.
45. Eccles R, Van Cauwenberge P, Tetzloff W, et al. A clinical study to evaluate the efficacy of the antihistamine doxylamine succinate in the relief of runny nose and sneezing associated with upper respiratory tract infection. J Pharm Pharmacol 47:990-993, 1995.
46. Turner RB, Sperber SJ, Sorrentino JV, et al. Effectiveness of Clemastine Fumarate for treatment of rhinorrhea and sneezing associated with the common cold. Clin Infect Dis 25:824-830, 1997.
47. Berkowitz RB, and Tinkelman DG. Evaluation of oral terfenadine for treatment of the common cold. Ann Allergy 67:593-597, 1991.
48. Hayden FG, Diamond L, Wood PB, et al. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 125:89-97, 1996.
49. Gwaltney JM Jr. Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis 166:776-782, 1992.